PECAM1 and Alzheimer disease: Meanwhile, we revealed that the increased inflammation/immune response and mitochondrial dysfunction in OB might be an essential susceptible factor for AD and identified novel gene candidates (MMP9, PECAM1, C3AR1, IL1R1, PPARGC1α, and COQ3) who could be used as biomarkers or as potential therapeutic targets.